Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo
Top Cited Papers
- 31 January 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 3 (4), 1558-1567
- https://doi.org/10.1039/c0nr00758g
Abstract
Curcumin is an effective and safe anticancer agent, but its hydrophobicity inhibits its clinical application. Nanotechnology provides an effective method to improve the water solubility of hydrophobic drug. In this work, curcumin was encapsulated into monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) (MPEG-PCL) micelles through a single-step nano-precipitation method, creating curcumin-loaded MPEG-PCL (Cur/MPEG-PCL) micelles. These Cur/MPEG-PCL micelles were monodisperse (PDI = 0.097 ± 0.011) with a mean particle size of 27.3 ± 1.3 nm, good re-solubility after freeze-drying, an encapsulation efficiency of 99.16 ± 1.02%, and drug loading of 12.95 ± 0.15%. Moreover, these micelles were prepared by a simple and reproducible procedure, making them potentially suitable for scale-up. Curcumin was molecularly dispersed in the PCL core of MPEG-PCL micelles, and could be slow-released in vitro. Encapsulation of curcumin in MPEG-PCL micelles improved the t1/2 and AUC of curcuminin vivo. As well as free curcumin, Cur/MPEG-PCL micelles efficiently inhibited the angiogenesis on transgenic zebrafish model. In an alginate-encapsulated cancer cell assay, intravenous application of Cur/MPEG-PCL micelles more efficiently inhibited the tumor cell-induced angiogenesisin vivo than that of free curcumin. MPEG-PCL micelle-encapsulated curcumin maintained the cytotoxicity of curcumin on C-26 colon carcinoma cellsin vitro. Intravenous application of Cur/MPEG-PCL micelle (25 mg kg−1curcumin) inhibited the growth of subcutaneous C-26 colon carcinoma in vivo (p < 0.01), and induced a stronger anticancer effect than that of free curcumin (p < 0.05). In conclusion, Cur/MPEG-PCL micelles are an excellent intravenously injectable aqueous formulation of curcumin; this formulation can inhibit the growth of colon carcinoma through inhibiting angiogenesis and directly killing cancer cells.Keywords
This publication has 56 references indexed in Scilit:
- RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochemical Pharmacology, 2010
- Preparation, characterization and applications of low-molecular-weight alginate–oligochitosan nanocapsulesNanoscale, 2009
- Encapsulation and Sustained Release of Curcumin using Superparamagnetic Silica ReservoirsChemistry – A European Journal, 2009
- Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future researchMolecular Nutrition & Food Research, 2008
- Application of Nanotechnology in Cancer Therapy and ImagingCA: A Cancer Journal for Clinicians, 2008
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapyJournal of Nanobiotechnology, 2007
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Preclinical assessment of curcumin as a potential therapy for B‐CLLAmerican Journal of Hematology, 2006
- Multiple biological activities of curcumin: A short reviewLife Sciences, 2006
- Drug discovery from medicinal plantsLife Sciences, 2005